2017
OR51 Correlation of class II antibody development with acute cellular rejection and fibrosis in pediatric liver transplantation
Bow L, Ekong U, Morotti R, Antala S, Emre S. OR51 Correlation of class II antibody development with acute cellular rejection and fibrosis in pediatric liver transplantation. Human Immunology 2017, 78: 47. DOI: 10.1016/j.humimm.2017.06.057.Peer-Reviewed Original ResearchAcute cellular rejectionClass II DSAPediatric liver transplantationLiver transplantationCellular rejectionHLA antibodiesFibrosis scoreDe novo HLA antibodiesNovo HLA antibodiesSided p valueDiagnosis of antibodyWilcoxon rank sumContinuous variablesGraft dysfunctionMean fibrosisSinusoidal fibrosisGraft functionPost transplantRejection gradeAvailable biopsiesLiver dysfunctionPatient characteristicsAntibody levelsDSA developmentSpecificity of antibodies
2015
Conundrum: A negative crossmatch in a patient with high level donor specific antibody
Rewinski M, Alberghini T, Bow L, Devivo J, Doyle P, Michalski P, Ortiz-Rivera J. Conundrum: A negative crossmatch in a patient with high level donor specific antibody. Human Immunology 2015, 76: 57. DOI: 10.1016/j.humimm.2015.07.082.Peer-Reviewed Original ResearchDonor-specific antibodiesB-cell crossmatchDonor-recipient pairsNegative crossmatchMedian fluorescence intensityVirtual crossmatchPresence of DSAPositive B cell crossmatchSpecific antibodiesIncompatible donor-recipient pairsFlow crossmatchAntibody levelsPositive donorsSAB assayAntibody testingHigh-resolution typingClinical significanceT cellsHLA typingPatient seraCrossmatchEP serumClass IIDQ7RT-PCR